Craft

Procept BioRobotics

Stock Price

$96.7

2024-10-29

Market Capitalization

$5 B

2024-10-29

Revenue

$308.1 M

FY, 2025

Procept BioRobotics Summary

Company Summary

Overview
Procept BioRobotics is a surgical robotics company that provides urologic care solutions. It develops, manufactures, and sells the AquaBeam robotic system for trans-urethral resection of prostate tissue, enabling physicians to target, control, and remove tissue to treat lower urinary tract symptoms.
Type
Public
Status
Active
Founded
2009
HQ
San Jose, CA, US | view all locations
Website
https://www.procept-biorobotics.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Reza Zadno

    Reza Zadno, President and Chief Executive Officer, Director

  • Kevin Waters

    Kevin Waters, Executive VP, Chief Financial Officer

  • Sham Shiblaq

    Sham Shiblaq, Executive VP, Chief Commercial Officer

  • Amy Dodrill, Director

    LocationsView all

    1 location detected

    • San Jose, CA HQ

      United States

      150 Baytech Drive

    Procept BioRobotics Financials

    Summary Financials

    Revenue (Q1, 2026)
    $83.1M
    Gross profit (Q1, 2026)
    $53.9M
    Net income (Q1, 2026)
    ($31.6M)
    Cash (Q1, 2026)
    $245.6M
    EBIT (Q1, 2026)
    ($32.6M)
    Enterprise value
    $4.9B

    Footer menu